- Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522-530.
- Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475-482.
- Pohlmann-Eden B, Beghi E, Camfield C, et al. The first seizure and its management in adults and children. BMJ. 2006;332(7537):339-342.
Hauser WA, Annegers JF, Rocca WA. Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proc. 1996;71(6):576-586.
World Health Organization. Epilepsy. June 20, 2019. Accessed April 12, 2021. https://www.who.int/news-room/fact-sheets/detail/epilepsy
- Heaney DC, MacDonald BK, Everitt A, et al. Socioeconomic variation in incidence of epilepsy: prospective community based study in south east England. BMJ. 2002;325(7371):1013-1016.
Angus-Leppan H. First seizures in adults [published correction appears in BMJ. 2014;348:g2977]. BMJ. 2014;348:g2470.
- Kaur S, Garg R, Aggarwal S, et al. Adult onset seizures: clinical, etiological, and radiological profile. J Family Med Prim Care. 2018;7(1):191-197.
Gavvala JR, Schuele SU. New-onset seizure in adults and adolescents: a review. JAMA. 2016;316(24):2657-2668.
Hauser WA, Beghi E. First seizure definitions and worldwide incidence and mortality. Epilepsia. 2008;49(suppl 1):8-12.
- Beghi E, Carpio A, Forsgren L, et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia. 2010;51(4):671-675.
Devinsky O, Schein A, Najjar S. Epilepsy associated with systemic autoimmune disorders. Epilepsy Curr. 2013;13(2):62-68.
Kumlien E, Lundberg PO. Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database. Seizure. 2010;19(2):69-73.
Misra UK, Kalita J. Management of provoked seizure. Ann Indian Acad Neurol. 2011;14(1):2-8.
Nardone R, Brigo F, Trinka E. Acute symptomatic seizures caused by electrolyte disturbances. J Clin Neurol. 2016;12(1):21-33.
- Sheldon R, Rose S, Ritchie D, et al. Historical criteria that distinguish syncope from seizures. J Am Coll Cardiol. 2002;40(1):142-148.
Therapeutic Research Center. Meds that increase seizure risk. Pharmacists' Letter. August 2017.
- Krumholz A, Wiebe S, Gronseth G, et al. Practice parameter: evaluating an apparent unprovoked first seizure in adults (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2007;69(21):1996-2007.
- Bernasconi A, Cendes F, Theodore WH, et al. Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: a consensus report from the International League Against Epilepsy Neuroimaging Task Force. Epilepsia. 2019;60(6):1054-1068.
- Huff JS, Melnick ER, Tomaszewski CA; American College of Emergency Physicians. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with seizures [published correction appears in Ann Emerg Med. 2017;70(5):758]. Ann Emerg Med. 2014;63(4):437-447.e15.
- Krumholz A, Wiebe S, Gronseth GS, et al. Evidence-based guideline: management of an unprovoked first seizure in adults: report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsy Curr. 2015;15(3):144-152.
- Rizvi S, Ladino LD, Hernandez-Ronquillo L, et al. Epidemiology of early stages of epilepsy: risk of seizure recurrence after a first seizure. Seizure. 2017;49:46-53.
- Kanemoto K, LaFrance WC, Duncan R, et al. PNES around the world: where we are now and how we can close the diagnosis and treatment gaps-an ILAE PNES Task Force report [published correction appears in Epilepsia Open. 2019;4(1):219]. Epilepsia Open. 2017;2(3):307-316.
- Martin R, Burneo JG, Prasad A, et al. Frequency of epilepsy in patients with psychogenic seizures monitored by video-EEG. Neurology. 2003;61(12):1791-1792.
- Szaflarski JP, Ficker DM, Cahill WT, et al. Four-year incidence of psychogenic nonepileptic seizures in adults in Hamilton County, OH. Neurology. 2000;55(10):1561-1563.
Rawlings GH, Reuber M. What patients say about living with psychogenic nonepileptic seizures: a systematic synthesis of qualitative studies. Seizure. 2016;41:100-111.
- Goldstein LH, Chalder T, Chigwedere C, et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology. 2010;74(24):1986-1994.
Chen H, Albertson TE, Olson KR. Treatment of drug-induced seizures. Br J Clin Pharmacol. 2016;81(3):412-419.
Thundiyil JG, Kearney TE, Olson KR. Evolving epidemiology of drug-induced seizures reported to a poison control center system. J Med Toxicol. 2007;3(1):15-19.
Zagaria ME. Common causes of drug-induced seizures. US Pharm. 2010;35(1):20-23.
- Hill T, Coupland C, Morriss R, et al. Antidepressant use and risk of epilepsy and seizures in people aged 20 to 64 years: cohort study using a primary care database. BMC Psychiatry. 2015;15:315.
- Lacroix C, Kheloufi F, Montastruc F, et al. Serious central nervous system side effects of cephalosporins: a national analysis of serious reports registered in the French Pharmacovigilance Database. J Neurol Sci. 2019;398:196-201.
- Pisani F, Oteri G, Costa C, et al. Effects of psychotropic drugs on seizure threshold. Drug Saf. 2002;25(2):91-110.
- Annegers JF, Shirts SB, Hauser WA, et al. Risk of recurrence after an initial unprovoked seizure. Epilepsia. 1986;27(1):43-50.
Chen DK, So YT, Fisher RS. Use of serum prolactin in diagnosing epileptic seizures: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology [last reaffirmed January 2019]. Neurology. 2005;65(5):668-675.
Abubakr A, Wambacq I. Diagnostic value of serum prolactin levels in PNES in the epilepsy monitoring unit. Neurol Clin Pract. 2016;6(2):116-119.
- Lusić I, Pintarić I, Hozo I, et al. Serum prolactin levels after seizure and syncopal attacks. Seizure. 1999;8(4):218-222.
- Lee RK, Burns J, Ajam AA, et al.; Expert Panel on Neurological Imaging. ACR appropriateness criteria: seizures and epilepsy. J Am Coll Radiol. 2020;17(5S):S293-S304.
Debicki DB. Electroencephalography after a single unprovoked seizure. Seizure. 2017;49:69-73.
- Leone MA, Giussani G, Nevitt SJ, et al. Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure. Cochrane Database Syst Rev. 2021;(5):CD007144.
- Leone MA, Vallalta R, Solari A, et al.; FIRST Group. Treatment of first tonic-clonic seizure does not affect mortality: long-term follow-up of a randomised clinical trial. J Neurol Neurosurg Psychiatry. 2011;82(8):924-927.
Perucca P, Gilliam FG. Adverse effects of antiepileptic drugs [published correction appears in Lancet Neurol. 2012;11(9):746]. Lancet Neurol. 2012;11(9):792-802.
- Jacoby A, Gamble C, Doughty J, et al.; Medical Research Council MESS Study Group. Quality of life outcomes of immediate or delayed treatment of early epilepsy and single seizures. Neurology. 2007;68(15):1188-1196.
Adams SM, Knowles PD. Evaluation of a first seizure. Am Fam Physician. 2007;75(9):1342-1347. Accessed October 21, 2021. https://www.aafp.org/afp/2007/0501/p1342.html
Wilden JA, Cohen-Gadol AA. Evaluation of first nonfebrile seizures. Am Fam Physician. 2012;86(4):334-340. Accessed October 21, 2021. https://www.aafp.org/afp/2012/0815/p334.html